Saturday, December 6th:


7:00 p.m. Welcome




Sunday, December 7th


8:45-9:00 a.m. Opening Remarks


Part 1: Costs of Insomnia
9:00-9:20 a.m. Performance/Quality of Life
James Walsh (USA)
9:20-9:30 a.m. Discussion
9:30-9:50 a.m. Pharmaco-economics/Direct Costs
Damien Léger (France)
9:50-10:00 a.m. Discussion
10:30-10:50 a.m. Psychiatric Co-Morbidity
Ruth Benca (USA)
10:50-11:00 a.m. Discussion
11:00-11:20 a.m. Epidemiological Perspectives
Maurice Ohayon (Canada)
11:20-11:30 a.m. Discussion
11:30-12:00 p.m. General Discussion


Part 2: Cognitive Function
4:00-4:20 p.m. Drug Effects
Malcolm Lader (United Kingdom)
4:20-4:30 p.m. Discussion
4:30-4:50 p.m. Sleep Disorders
Meir Kryger (Canada)
4:50-5:00 p.m. Discussion
5:00-5:20 p.m. Sleep and Memory
Timothy Roehrs (USA)
5:20-5:30 p.m. Discussion
5:30-6:00 p.m. General Discussion





Monday, December 8th

Part 3: Primary Care
9:00-9:20 a.m. Insomnia Management
Göran Hajak (Germany)
9:20-9:30 a.m. Discussion
9:30-9:50 a.m. Resident Training
Steve Brunton (USA)
9:50-10:00 a.m. Discussion
10:30-10:50 a.m. Diagnosis of Insomnia
Bedirhan Üstün (Turkey)
10:50-11:00 a.m. Discussion
11:00-11:20 a.m. Epidemiological Implications
Terry Young (USA)
11:20-11:30 a.m. Discussion
11:30-12:00 p.m. General Discussion


Part 4: Circadian Rhythms
4:00-4:20 p.m. Pharmacologic and Hormonal Manipulations
Gary Richardson (USA)
4:20-4:30 p.m. Discussion
4:30-4:50 p.m. Insomnia/Psychiatry
Daniel Buysse (USA)
4:50-5:00 p.m. Discussion
5:00-5:20 p.m. Circadian Clocks/Aging
Jeanne Duffy (USA)
5:20-5:30 p.m. Discussion
5:30-6:00 p.m. General Discussion





Tuesday, December 9th


Part 5: Challenges/Opportunities/Speculations
9:00-9:30 a.m. Costs of Insomnia: Summary/Discussion
Thomas Roth (USA)
9:30-10:00 a.m. Cognitive Function: Summary/Discussion
Eduardo Estivill-Sancho (Spain)
10:30-11:00 a.m. Primary Care: Summary/Discussion
Teresa Paiva (Portugal)
11:00-11:30 a.m. Circadian Rhythms: Summary/Discussion
Liborio Parrino (Italy)
11:30-12:00 p.m. Closing Remarks







top